• Users Online: 125
  • Print this page
  • Email this page
DRUG REVIEW
Year : 2017  |  Volume : 55  |  Issue : 2  |  Page : 134-139

Newer drugs in glaucoma management


Smt. Jadhavbai Nathmal Singhvi Glaucoma Services, Sankara Nethralaya, Chennai, Tamil Nadu, India

Correspondence Address:
Dr. Sujatha V Kadambi
Smt. Jadhavbai Nathmal Singhvi Glaucoma Services, Sankara Nethralaya, Chennai, Tamil Nadu
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/tjosr.tjosr_24_17

Get Permissions

Glaucoma, a chronic progressive neurodegenerative disease, has both intraocular pressure dependent and independent pathogenetic mechanisms. Medical therapy is the first line of treatment in glaucoma management. Patient adherence and persistence to pharmacotherapy is a great barrier to its success. This review highlights the recent advances in medical management and discusses newer pharmacotherapy including new molecules with novel mechanisms of action, novel target molecules/genes/tissues, and newer drug delivery systems, many of which are still in clinical trial phase.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1234    
    Printed53    
    Emailed0    
    PDF Downloaded228    
    Comments [Add]    

Recommend this journal